Todd Hobbs

Company: Diasome Pharmaceuticals

Job title: Chief Medical Officer

Seminars:

Oral Delivery of GLP-1 and other Incretins: Targeting both Hepatic and Peripheral Uptake to Improve Patient Outcomes 4:15 pm

Hepatic targeting of incretins in metabolic diseases – the importance of mimicking normal physiology Highlighting a novel oral delivery platform, hepatic directed vesicles (HDV) Reviewing the potential benefits of dual targeting for GLP-1 in both hepatic and peripheral uptakeRead more

day: Conference Day One